Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_47769 | 70 | 1.46 | Mlig455_034062 | Neo: - Age: Down-Down-Up |
CHRNA6 | Mlig455_034062 {REF} {Length: 2693} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=120.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=92.9]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=199, Expect=3e-57]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=195, Expect=8e-56]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=190, Expect=3e-54]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=200, Expect=6e-58]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=198, Expect=3e-57]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=193, Expect=1e-55]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=190, Expect=5e-54]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=206, Expect=2e-59]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=200, Expect=1e-57]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=195, Expect=4e-56]} {RNA1310_10964.1} {RNA815_16260.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.046 | 1.422 | 0.99969 | 1.00000 | |
RegionR2 | 2.696 | 1.422 | 0.07242 | 0.32841 | |
RegionR3 | 0.149 | 1.422 | 0.76325 | 1.00000 | |
RegionR4 | -1.304 | 1.422 | 0.98255 | 1.00000 | |
RegionR5 | 0.141 | 1.422 | 0.75357 | 1.00000 | |
RegionR6 | 2.258 | 1.422 | 0.07846 | 0.51874 | |
RegionR7 | 1.578 | 1.422 | 0.35103 | 0.98724 | |
RegionR8 | -2.473 | 1.422 | 0.99961 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.764 | 1.422 | 0.99996 | 1.00000 | |
RegenerationR2 | -0.647 | 1.422 | 0.37782 | 0.80032 | |
RegenerationR3 | 0.947 | 1.422 | 0.48362 | 0.85214 | |
RegenerationR4 | 1.679 | 1.422 | 0.15694 | 0.58834 | |
RegenerationR5 | 0.832 | 1.422 | 0.45005 | 0.83096 | |
RegenerationR6 | 0.355 | 1.422 | 0.76828 | 0.96095 | |
RegenerationBL | 0.001 | 1.422 | 0.81990 | 1.00000 | |
RegenerationTP | 2.714 | 1.422 | 0.23275 | 0.67812 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_47769 | 70 | 1.46 | Mlig455_034062 | Neo: - Age: Down-Down-Up |
CHRNA6 | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_034062 {REF} {Length: 2693} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=120.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=92.9]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=199, Expect=3e-57]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=195, Expect=8e-56]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=190, Expect=3e-54]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=200, Expect=6e-58]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=198, Expect=3e-57]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=193, Expect=1e-55]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=190, Expect=5e-54]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=206, Expect=2e-59]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=200, Expect=1e-57]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=195, Expect=4e-56]} {RNA1310_10964.1} {RNA815_16260.1} |
2. | MligTC455_26517 | 54 | 1.13 | Mlig455_050870, Mlig455_053969 | Neo: - Age: logFC(26M/2M)=-0.514 |
1.822 | - | - | 0.832 | - | 0.990 | - | Mlig455_050870 {REF} {Length: 3430} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=54.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.7]} {Smed: dd_Smed_v6_6819_0_2, dd_Smed_v6_6819_0_2, [Score=152, Expect=9e-42]} {RNA1509_35362} {RNA1310_8376} {RNA815_4529} Mlig455_053969 {REF} {Length: 989} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=74.2]} {Smed: dd_Smed_v6_16441_0_5, dd_Smed_v6_16441_0_5, [Score=51.6, Expect=3e-07]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
3. | MligTC455_52886 | 457 | 9.52 | Mlig455_060949 | Neo: - Age: logFC(26M/2M)=0.945 |
1.794 | - | - | - | 0.958 | 0.836 | - | Mlig455_060949 {REF} {Length: 1307} {Pfam: Kazal-type serine protease inhibitor domain [PF00050.23, score=70.7]; Kazal-type serine protease inhibitor domain [PF07648.17, score=62.7]} {Dmel: FBgn0052354, CG32354, [Score=48.1, Expect=3e-06]} {Smed: dd_Smed_v6_3649_0_1, dd_Smed_v6_3649_0_1, [Score=49.7, Expect=6e-07]} {RNA1509_43736} {RNA1310_25866.2} {RNA815_10610.1} | |
4. | MligTC455_47770 | 39 | 0.81 | Mlig455_060420 | Neo: - Age: - |
CHRNA9 | 1.777 | - | - | 0.795 | 0.982 | - | - | Mlig455_060420 {REF} {Length: 2482} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=131.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=202, Expect=2e-58]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=199, Expect=4e-57]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=199, Expect=1e-56]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=196, Expect=2e-56]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=196, Expect=1e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=196, Expect=1e-55]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=195, Expect=3e-55]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=4e-60]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=206, Expect=6e-60]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=199, Expect=1e-57]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=199, Expect=9e-57]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=197, Expect=4e-56]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=213, Expect=2e-61]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=206, Expect=1e-59]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=204, Expect=8e-59]} {RNA1310_10964.1} {RNA815_21155} |
5. | MligTC455_37325 | 21 | 0.45 | Mlig455_053385 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_053385 {REF} {Length: 347} {NoTransDecoderORF} {RNA1509_46225} {RNA1310_43662} | |
6. | MligTC455_13778 | 74 | 1.55 | Mlig455_057444 | Neo: - Age: Up-Down-Down |
FGG | 0.962 | - | - | - | - | - | 0.962 | Mlig455_057444 {REF} {Length: 1868} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.2]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=96.3, Expect=4e-22]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.4, Expect=3e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=92.4, Expect=1e-20]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=92.0, Expect=2e-20]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=97.4, Expect=2e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=84.0, Expect=7e-18]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.8, Expect=2e-14]} {RNA1509_51521} {RNA1310_49947} {RNA815_34508} |
7. | MligTC455_36639 | 17 | 0.35 | Mlig455_054487 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_054487 {REF} {Length: 3547} {RNA1509_42521} {RNA1310_16590} {RNA815_20255} | |
8. | MligTC455_31978 | 17 | 0.36 | Mlig455_065471 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_065471 {REF} {Length: 1840} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.5]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=65.9, Expect=7e-12]} {RNA1509_46373} {RNA1310_112946} {RNA815_7856.1} | |
9. | MligTC455_50975 | 173 | 3.6 | Mlig455_014388 | Neo: - Age: Down-Up-Up |
CHRNB3 | 0.959 | - | - | - | 0.959 | - | - | Mlig455_014388 {REF} {Length: 1742} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=23.6]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=110, Expect=4e-26]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=108, Expect=2e-25]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=107, Expect=5e-25]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=106, Expect=9e-25]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=106, Expect=7e-25]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=105, Expect=2e-24]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=114, Expect=5e-28]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=107, Expect=2e-25]} {Celegans: WBGene00000955, des-2, Acetylcholine receptor subunit alpha-type des-2, [Score=104, Expect=2e-24]} {Smed: dd_Smed_v6_26232_0_1, dd_Smed_v6_26232_0_1, [Score=157, Expect=2e-43]} {RNA1310_54548} {RNA815_33490} |
10. | MligTC455_37262 | 141 | 2.93 | Mlig455_020634 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_020634 {REF} {Length: 1702} {RNA1509_58758} {RNA1310_66307} {RNA815_948.1} | |
11. | MligTC455_22503 | 206 | 4.29 | Mlig455_013995 | Neo: - Age: - |
NAXE | 0.953 | - | - | 0.953 | - | - | - | Mlig455_013995 {REF} {Length: 2090} {Pfam: YjeF-related protein N-terminus [PF03853.17, score=113.5]} {Human: ENSG00000163382, NAXE, NAD(P)HX epimerase, [Score=229, Expect=6e-72]} {Mouse: ENSMUSG00000028070, Naxe, NAD(P)HX epimerase, [Score=231, Expect=9e-73]} {Dmel: FBgn0030178, CG2974, [Score=194, Expect=1e-59]} {Celegans: WBGene00012476, Y18D10A.3, NAD(P)H-hydrate epimerase, [Score=165, Expect=9e-47]} {Smed: dd_Smed_v6_9067_0_1, dd_Smed_v6_9067_0_1, [Score=219, Expect=1e-68]} {RNA1509_45350} {RNA1310_22217.1} {RNA815_13669} |
12. | MligTC455_14659 | 29 | 0.6 | Mlig455_008399 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_008399 {REF} {Length: 613} {NoTransDecoderORF} {RNA1509_54373} {RNA1310_125370} | |
13. | MligTC455_46403 | 73 | 1.53 | Mlig455_020746 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_020746 {REF} {Length: 668} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_47399.1} {RNA815_38310} |